Agilent and Paradigm Genetics to Develop Arabidopsis Genome Chip | GenomeWeb

NEW YORK, Oct. 29 — Agilent Technologies and Paradigm Genetics announced a deal on Monday to develop a microarray of the whole genome of Arabidopsis thaliana

Palo Alto, Calif.-based Agilent will design, manufacture, distribute and sell the microarray. Paradigm will provide gene function expertise. The two companies plan to have the product ready for market by the end of the year. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.